Cost-effectiveness of overactive bladder treatments: From the US payer perspective

  • Brian Murray
  • , Sam H. Hessami
  • , Dmitry Gultyaev
  • , Johanna Lister
  • , Roger Dmochowski
  • , Kristin Khalaf Gillard
  • , Sanja Stanisic
  • , Amy Tung
  • , Robert Boer
  • , Steven Kaplan

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-effectiveness of overactive bladder treatments: From the US payer perspective'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science